Welcome!

News Feed Item

Worldwide Medical Polymer Markets: 2013-2020

NEW YORK, March 19, 2014 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Worldwide Medical Polymer Markets: 2013-2020
http://www.reportlinker.com/p01628707/Worldwide-Medical-Polymer-Markets-2013-2020.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Plastic

SUMMARY

NanoMarkets believes that medical polymers represents a major opportunity in the medical materials market over the next few years. Several factors are leading to growth in this market. Perhaps the most obvious is the aging of the population in developed nations is expanding the addressable market for polymer implants. Many polymer implants are specifically intended to assist elder patients.
Opportunity in this market has also expanded because the latest technical developments in medical polymers can fine tune implant capabilities, enable better fits for implants, and increased biocompatibility. Polymer structures can also now substitute for cartilage or enable doctors to grow a patient's tissue for transplants.
At the same time the new legal protections that followed the silicone breast implant debacle have considerably reduced the risk in the medical polymer space. And as a result of all of these factors, the medical polymer business has taken off, with the emergence of new start ups and plenty of M&A activity.

With all that is happening in this space, NanoMarkets is publishing a report that identifies current and future opportunities in the medical polymers space and provides guidance on the technical and regulatory framework in which these opportunities are arising. As with all NanoMarkets reports in the medical materials field, this report includes a granular eight-year forecast and also profiles key suppliers and analyzes the complete supply chain for medical polymers. For the firms covered we discuss their strategies and needs along with their strengths and weaknesses. Finally, the report provides an analysis of the market for medical polymers in various important country-specific markets.

Readers of this report will gain the following:

• An analytical review of polymers used for medical applications, including developing implants, diagnostic systems, and hospital labware.
• Knowledge on current technical and market trends, including general market drivers for improvement in the healthcare sector, polymer production, and evaluation for clinical approval.
• An understanding of key medical products and their future implications.
• A pin-pointed analysis of the changing dynamics of polymer producers.
• Eight–year forecasts based on expected market growth.
• A brief technological road map for understanding industry growth.
• Profiles of major companies operating as manufacturers of medical polymers.
• Insight into important geographical locations pertaining to polymer and healthcare sectors.
• Information on the size of the medical polymer market in developed nations and the fast-growing economies in Asia, such as China and India.
• Details of the regulatory requirements of these countries for producing high-quality, medically approved polymers and their use in various applications.
• Help in making business decisions for venturing into the medical polymer market.
• Descriptive and distinctive graphics, along with concise, tabular analyses of various domains.

Executive Summary
E.1 Opportunities in the Medical Device Market
E.2 Opportunities for the Plastics Industry
E.3 Firms and Strategies to Watch in the Medical Polymer Market
E.3.1 Bayer MaterialScience
E.3.2 Celanese
E.3.3 Dow Corning
E.3.4 Dow Chemical
E.3.5 DSM
E.3.6 DuPont
E.3.7 Eastman Chemical
E.3.8 Evonik
E.3.9 Solvay
E.4 Summary of Eight-Year Forecasts of the Medical Polymer Market

Chapter One: Introduction
1.1 Background to this Report
1.1.1 Boom in Thermoplastic Elastomers (TPES) and Engineered Plastics (Super Specialty Plastics)
1.1.2 Rise of Degradable Polymers
1.1.3 Important Points for Manufacturers
1.2 Scope and Objectives of this Report
1.3 Methodology and Information Sources
1.4 Plan of this Report
Chapter Two: Commercial Trends in Medical Polymers
2.1 Generic Advantages and Disadvantages of Polymers for Medical Applications
2.1.1 Advantages of Polymers in Medical Applications
2.1.2 Disadvantages of Polymers in Medical Applications
2.1.3 Replacement of Metals with Polymers in Medical Devices
2.2 Thermoplastics (PMMA, PLA, PGA, PP, PEEK, Polycarbonates)
2.2.1 Uses of Thermoplastics in Medical Applications
2.2.2 Main Suppliers of Thermoplastics for Medical Applications
2.3 Polyethylene (PE)
2.3.1 Uses of PE in Medical Applications

2.3.2 Main Suppliers of PE for Medical Applications
2.4 Polystyrene
2.4.1 Uses of Polystyrene and Styrenics in Medical Applications
2.4.2 Main Suppliers of PS for Medical Applications
2.5 Polyvinyl Chloride
2.5.1 Uses of PVC in Medical Applications
2.5.2 Main Suppliers of PVC for Medical Applications
2.6 Nylon
2.6.1 Uses of Nylon in Medical Applications
2.6.2 Main Suppliers of Nylon for Medical Applications
2.7 Other Polymers for Medical Applications
2.8 Role of Bioplastics in Medical Applications
2.9 Key Points from this Chapter
Chapter Three: Applications for Medical Polymers
3.1 Pricing and Forecast Assumptions
3.1.1 Explanation of Polymer Pricing
3.1.2 Use of Medical Polymers in Different Applications
3.2 Medical Devices and Implants
3.2.1 Current and Future Use of Polymers
3.2.2 Regenerative Medicine and Orthopedic Implants
3.2.3 Contact Lenses and Lens Implants

3.2.4 Implantable Defibrillators and Related Devices
3.2.5 Breast Implants
3.2.6 Conductive Polymer Neural Implants
3.2.7 Blood Filters
3.2.8 Other Medical Devices Using Polymers
3.3 Eight-Year Forecast of Polymers in Implants by Polymer and Implant Type
3.4 Eight-Year Forecast of Polymers in Non-Implantable Devices by Polymer and Device Type
3.4.1 Diagnostic Systems
3.5 Eight-Year Forecast of Polymers in Diagnostic Systems by Polymer and Device Type
3.5.1 Laboratory and Surgical Accessories and Disposables
3.5.2 Surgical Screws, Nails and Plates
3.5.3 Catheters and Tubing
3.5.4 Surgical Gloves
3.5.5 Sutures and Shunts
3.6 Eight-Year Forecast of Polymers in Diagnostic Systems by Polymer and Device Type
3.7 Summary of Forecasts of Medical Polymers
3.7.1 Summary Forecast of Medical Polymers by Application
3.8 Summary Forecast of Medical Polymers by Polymer Type
3.9 Key Points in this Chapter
Chapter Four: National Markets and Regulatory Factors
4.1 Generic Policy Issues Raised by Polymer Medical Devices
4.1.1 Safety Issues Related to Polymer Devices
4.1.2 Problems of Waste Disposal and Management in Medical Polymer Manufacturing
4.1.3 Healthcare Issues and an Aging Population
4.1.4 Geographical Distribution of the Markets
4.2 The Medical Polymer Market in the United States
4.2.1 Medical Polymers and the Biomaterials Access Assurance Act of 1998
4.2.2 Impact of "Obamacare"

4.2.3 Role and Impact of the FDA
4.2.4 Analysis of the Market for Medical Polymers in the U.S.
4.2.5 Eight-Year Forecasts for Medical Polymers in the U.S.
4.3 The Medical Polymer Market in Europe
4.3.1 Role and Impact of the European Commission and Other Regulatory Authorities in the European Union
4.3.2 National Regulations and Regulatory Agencies Impacting Medical Polymer Markets in the EU
4.3.3 Analysis of the Market for Medical Polymers in Europe
4.3.4 Eight-Year Forecast for Medical Polymers in Europe
4.4 The Medical Polymer Market in Japan
4.4.1 National Laws and Regulations Impacting the Medical Polymer Market in Japan
4.4.2 Analysis of Market for Medical Polymers in Japan
4.4.3 Eight-Year Forecast for Medical Polymers in Japan
4.5 The Medical Polymer Market in China
4.5.1 National Laws and Regulations Impacting the Medical Polymer Market in China
4.5.2 Impact of Chinese Industrial Policy on the Medical Polymer Market
4.5.3 Analysis of the Market for Medical Polymers in China
4.5.4 Eight-Year Forecast for Medical Polymers in China
4.6 The Medical Polymer Market in India
4.6.1 National Laws and Regulations Impacting the Medical Polymer Market in India
4.6.2 Analysis of the Market for Medical Polymers in India
4.6.3 Eight-Year Forecast for Medical Polymers in India
4.7 Other Notable National Markets for Medical Polymers
4.7.1 The Medical Polymer Market in Canada
4.7.2 The Medical Polymer Market in Australia
4.7.3 The Medical Polymer Market in South Korea
4.8 Summary of Eight-Year Forecasts of Medical Polymers by Country
Acronyms and Abbreviations Used In this Report
About the Author

List of Exhibits

Exhibit E-1: Summary Forecast of Medical Polymers by Application ( US$ Millions)
Exhibit 2-1: Important Advantages of Polymers and Their Current Applications
Exhibit 2-2: Thermoplastics - Properties and Uses
Exhibit 2-3: Common Suppliers of Thermoplastics
Exhibit 2-4: Opportunities for Different PE Grades
Exhibit 2-5: Different Suppliers of Polyethylene Products and their Features
Exhibit 2-6: Requirements and Medical Applications for Various Types of PS
Exhibit 2-7: Suppliers Of GPPS, HIPS, and SPS Products for Medical Applications and their Trade Names
Exhibit 2-8: Suppliers and Characteristics of Flexible, Rigid and Semi-rigid Medical Grades of PVC
Exhibit 2-9: Nylon Products and Manufacturers
Exhibit 2-10: Medical Devices and Implants Made from Polyurethanes
Exhibit 2-11: Leading Teflon products, Their Manufacturers, and Application Areas
Exhibit 3-1: Pricing of Polymers and Polymer-Based Medical Products
Exhibit 3-2: Approximate Market Share of Different Polymer Types in Each Application
Exhibit 3-3: Selected Polymeric Orthopedic Products, their Manufacturers and Opportunities
Exhibit 3-4: Approved Breast Implants and their Market Opportunities
Exhibit 3-5: Overview of Important Blood Filters
Exhibit 3-6: Overview of Selected Wound Dressing Materials

Exhibit 3-7: Orthopedic Implants and Regenerative Medicines Forecast
Exhibit 3-8: Forecast of Polymer Use In Lens Implants
Exhibit 3-9: Forecast of Polymer Use in Contact Lenses
Exhibit 3-10: Forecast of Polymer Use in Implantable Defibrillators
Exhibit 3-11: Forecast of Polymer Use In Breast Implants
Exhibit 3-12: Forecast of Conductive Polymer Use In Neural Implants
Exhibit 3-13: Forecast of Polymer Use In Blood Filters
Exhibit 3-14: Forecast of Polymer Use In Other Medical Devices
Exhibit 3-15: Polymers Used in Diagnostic Devices and Their Future Opportunities
Exhibit 3-16: Forecast of Polymer Use In Diagnostic Devices
Exhibit 3-17: Forecast of Polymer Use In Automated Analyzers
Exhibit 3-18: Forecast of Polymer Use In Homecare Diagnostic Devices
Exhibit 3-19: Forecast of Polymer Use In Point-of-Care (POC) Diagnostics
Exhibit 3-20: Overview of Important Polymers for Multiple-Use and Disposable Labware Fabrication
Exhibit 3-21: Leading Labware Manufacturers and Their Brands and Market Potential
Exhibit 3-22: Selected Catheter and Tubing Products
Exhibit 3-23: Surgical Gloves and Their Specifications
Exhibit 3-24: Forecast of Polymer Use In Surgical Screws, Nails and Plates
Exhibit 3-25: Forecast of Polymer Use In Catheters and Tubing
Exhibit 3-26: Forecast of Polymer Use In Surgical Gloves
Exhibit 3-27: Forecast of Polymer Use In Sutures and Shunts
Exhibit 3-28: Summary Forecast of Medical Polymers by Application (US $Millions)
Exhibit 3-29: Summary Forecast by Top Polymer Types (U.S.$ Millions)
Exhibit 4-1: Key Industry Issues, Their Impacts, and Probable Solutions
Exhibit 4-2: Important U.S. Regulations Affecting Medical Polymers
Exhibit 4-3: Key Players in the U.S. Medical Polymer Industry Responding to Major Trends
Exhibit 4-4: Eight-Year Forecast of Medical Polymers in the U.S. (US$ Millions)
Exhibit 4-5: Key EC Regulations and Their Significance
Exhibit 4-6: Recent Technology Developments in Europe
Exhibit 4-7: Eight-Year Forecast for Medical Polymers in Europe (US$ Millions)

Exhibit 4-8: Important Regulations in Japan and Their Impact on the Medical Polymers Market
Exhibit 4-9: Recent Technology Developments in Japan
Exhibit 4-10: Eight-Year Forecast for Medical Polymers in Japan (US $Millions)
Exhibit 4-11: Key Impacts of CFDA Policies and Opportunities for Policy Improvement in China
Exhibit 4-12: Recent Technology Developments in China
Exhibit 4-13: Eight-Year Forecast for Medical Polymers in China (US $Millions)
Exhibit 4-14: Key Regulatory Impacts and Opportunities for Policy Improvement in India
Exhibit 4-15: Recent Technology Developments in India
Exhibit 4-16: Eight-Year Forecast for Medical Polymers in India (US $Millions)
Exhibit 4-17: Regulatory Scenario and Industry Opportunities in Other Markets
Exhibit 4-18: Global Eight-Year Forecast for Medical Polymers Broken Out by Country/Region

To order this report: Worldwide Medical Polymer Markets: 2013-2020
http://www.reportlinker.com/p01628707/Worldwide-Medical-Polymer-Markets-2013-2020.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Plastic

__________________________
Contact Clare: [email protected]
US: (339)-368-6001
Intl: +1 339-368-6001

SOURCE Reportlinker

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
The goal of Continuous Testing is to shift testing left to find defects earlier and release software faster. This can be achieved by integrating a set of open source functional and performance testing tools in the early stages of your software delivery lifecycle. There is one process that binds all application delivery stages together into one well-orchestrated machine: Continuous Testing. Continuous Testing is the conveyer belt between the Software Factory and production stages. Artifacts are m...
WebRTC is the future of browser-to-browser communications, and continues to make inroads into the traditional, difficult, plug-in web communications world. The 6th WebRTC Summit continues our tradition of delivering the latest and greatest presentations within the world of WebRTC. Topics include voice calling, video chat, P2P file sharing, and use cases that have already leveraged the power and convenience of WebRTC.
Cloud resources, although available in abundance, are inherently volatile. For transactional computing, like ERP and most enterprise software, this is a challenge as transactional integrity and data fidelity is paramount – making it a challenge to create cloud native applications while relying on RDBMS. In his session at 21st Cloud Expo, Claus Jepsen, Chief Architect and Head of Innovation Labs at Unit4, will explore that in order to create distributed and scalable solutions ensuring high availa...
For financial firms, the cloud is going to increasingly become a crucial part of dealing with customers over the next five years and beyond, particularly with the growing use and acceptance of virtual currencies. There are new data storage paradigms on the horizon that will deliver secure solutions for storing and moving sensitive financial data around the world without touching terrestrial networks. In his session at 20th Cloud Expo, Cliff Beek, President of Cloud Constellation Corporation, d...
Internet-of-Things discussions can end up either going down the consumer gadget rabbit hole or focused on the sort of data logging that industrial manufacturers have been doing forever. However, in fact, companies today are already using IoT data both to optimize their operational technology and to improve the experience of customer interactions in novel ways. In his session at @ThingsExpo, Gordon Haff, Red Hat Technology Evangelist, shared examples from a wide range of industries – including en...
In IT, we sometimes coin terms for things before we know exactly what they are and how they’ll be used. The resulting terms may capture a common set of aspirations and goals – as “cloud” did broadly for on-demand, self-service, and flexible computing. But such a term can also lump together diverse and even competing practices, technologies, and priorities to the point where important distinctions are glossed over and lost.
In his session at @DevOpsSummit at 20th Cloud Expo, Kelly Looney, director of DevOps consulting for Skytap, showed how an incremental approach to introducing containers into complex, distributed applications results in modernization with less risk and more reward. He also shared the story of how Skytap used Docker to get out of the business of managing infrastructure, and into the business of delivering innovation and business value. Attendees learned how up-front planning allows for a clean sep...
Most companies are adopting or evaluating container technology - Docker in particular - to speed up application deployment, drive down cost, ease management and make application delivery more flexible overall. As with most new architectures, this dream takes a lot of work to become a reality. Even when you do get your application componentized enough and packaged properly, there are still challenges for DevOps teams to making the shift to continuous delivery and achieving that reduction in cost ...
Detecting internal user threats in the Big Data eco-system is challenging and cumbersome. Many organizations monitor internal usage of the Big Data eco-system using a set of alerts. This is not a scalable process given the increase in the number of alerts with the accelerating growth in data volume and user base. Organizations are increasingly leveraging machine learning to monitor only those data elements that are sensitive and critical, autonomously establish monitoring policies, and to detect...
Enterprise architects are increasingly adopting multi-cloud strategies as they seek to utilize existing data center assets, leverage the advantages of cloud computing and avoid cloud vendor lock-in. This requires a globally aware traffic management strategy that can monitor infrastructure health across data centers and end-user experience globally, while responding to control changes and system specification at the speed of today’s DevOps teams. In his session at 20th Cloud Expo, Josh Gray, Chie...
To get the most out of their data, successful companies are not focusing on queries and data lakes, they are actively integrating analytics into their operations with a data-first application development approach. Real-time adjustments to improve revenues, reduce costs, or mitigate risk rely on applications that minimize latency on a variety of data sources. Jack Norris reviews best practices to show how companies develop, deploy, and dynamically update these applications and how this data-first...
Intelligent Automation is now one of the key business imperatives for CIOs and CISOs impacting all areas of business today. In his session at 21st Cloud Expo, Brian Boeggeman, VP Alliances & Partnerships at Ayehu, will talk about how business value is created and delivered through intelligent automation to today’s enterprises. The open ecosystem platform approach toward Intelligent Automation that Ayehu delivers to the market is core to enabling the creation of the self-driving enterprise.
"At the keynote this morning we spoke about the value proposition of Nutanix, of having a DevOps culture and a mindset, and the business outcomes of achieving agility and scale, which everybody here is trying to accomplish," noted Mark Lavi, DevOps Solution Architect at Nutanix, in this SYS-CON.tv interview at @DevOpsSummit at 20th Cloud Expo, held June 6-8, 2017, at the Javits Center in New York City, NY.
"We're here to tell the world about our cloud-scale infrastructure that we have at Juniper combined with the world-class security that we put into the cloud," explained Lisa Guess, VP of Systems Engineering at Juniper Networks, in this SYS-CON.tv interview at 20th Cloud Expo, held June 6-8, 2017, at the Javits Center in New York City, NY.
Historically, some banking activities such as trading have been relying heavily on analytics and cutting edge algorithmic tools. The coming of age of powerful data analytics solutions combined with the development of intelligent algorithms have created new opportunities for financial institutions. In his session at 20th Cloud Expo, Sebastien Meunier, Head of Digital for North America at Chappuis Halder & Co., discussed how these tools can be leveraged to develop a lasting competitive advantage ...